Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2 (replacing v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:14:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1. No study content or data appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T15:00:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The notice regarding a lapse in government funding and potential data updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:38:47.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes detected in core content; only cosmetic formatting changes were observed on the Study Details page, and there are no updates to inclusion criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:27:12.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:31:00.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and page version bumped from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:20:24.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.